Media Releases › Arovella Therapeutics

SUDA Pharmaceuticals Ltd (ASX:SUD), a leader in oro-mucosal drug delivery, released an amended Appendix 4C which had been released 31 January 2019. 


For more information, download the attached PDF.


  Download this document